Irene Leung Selected Research

Serine (L-Serine)

1/2021

Genetic disruption of serine biosynthesis is a key driver of macular telangiectasia type 2 aetiology and progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Irene Leung Research Topics

Disease

8	Telangiectasis (Telangiectasia) 01/2021 - 12/2011
4	Macular Degeneration (Age-Related Maculopathy) 10/2017 - 07/2015
2	Rheumatoid Arthritis 05/2014 - 05/2013
1	Neoplasms (Cancer) 07/2023
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Atrophy 06/2019
1	Retinoschisis (Retinoschisis, Juvenile) 06/2019
1	Epiretinal Membrane (Epiretinal Membranes) 06/2019
1	Retinal Perforations 06/2019
1	Cerebral Small Vessel Diseases 01/2018
1	Eye Diseases (Eye Disease) 10/2017
1	Cataract (Cataracts) 01/2017
1	Tetanus 05/2014
1	Distal Humeral Fractures 01/2009
1	AIDS-Related Complex (ARC) 01/2009

Drug/Important Bio-Agent (IBA)

7	Retinaldehyde (Retinal)IBA 01/2021 - 12/2011
3	Macular PigmentIBA 10/2017 - 12/2015
2	Proteins (Proteins, Gene)FDA Link 07/2023 - 05/2013
1	InterleukinsIBA 07/2023
1	CytokinesIBA 07/2023
1	Interleukin-15 Receptors (Interleukin 15 Receptor)IBA 07/2023
1	Serine (L-Serine)FDA Link 01/2021
1	Estrogens (Estrogen)FDA Link 01/2018
1	Hormones (Hormone)IBA 01/2018
1	Tamoxifen FDA LinkGeneric 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Ciliary Neurotrophic Factor (CNTF)IBA 01/2018
1	ZincIBA 10/2017
1	meso-zeaxanthinIBA 10/2017
1	Carotenoids (Carotene)IBA 10/2017
1	AntioxidantsIBA 10/2017
1	Fluorescein (Funduscein)FDA LinkGeneric 04/2015
1	Immunoglobulin G (IgG)IBA 05/2014
1	Immunoglobulin M (IgM)IBA 05/2014
1	B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA 05/2014
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 07/2013
1	Immunosuppressive Agents (Immunosuppressants)IBA 05/2013
1	Abatacept (Orencia)FDA Link 05/2013
1	TeaIBA 01/2009

Therapy/Procedure

1	Traction 06/2019
1	Lasers (Laser) 04/2019
1	Therapeutics 01/2018
1	Arthroplasty 01/2009